Alpine Global Management, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Alpine Global Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$0.52 - $0.92 $10,555 - $18,675	-20,299 Closed	0 $0
Q1 2020 Apr 09, 2020	SELL	$0.6 - $2.31 $24,357 - $93,774	-40,595 Reduced 66.67%	20,299 $12,000
Q4 2019 Jan 16, 2020	BUY	$0.63 - $2.27 $38,363 - $138,229	60,894 New	60,894 $138,000
Q1 2019 May 10, 2019	SELL	$0.6 - $1.41 $247,501 - $581,629	-412,503 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.53 - $1.11 $218,626 - $457,878	412,503 New	412,503 $245,000
Q3 2018 Nov 15, 2018	SELL	$0.35 - $0.92 $44,115 - $115,960	-126,044 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$0.42 - $0.74 $52,938 - $93,272	126,044 New	126,044 $55,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.